Wednesday, September 16, 2026
ExploreSearch
Finance Via News

Corporate Innovation

2 articles

NVIDIA Signs Eli Lilly, Thermo Fisher to BioNeMo Platform in Pharmaceutical AI Push

NVIDIA Signs Eli Lilly, Thermo Fisher to BioNeMo Platform in Pharmaceutical AI Push

NVIDIA has secured partnerships with Eli Lilly and Thermo Fisher Scientific for its BioNeMo AI platform, targeting drug discovery infrastructure.<sup>1</sup> Multiple biotech firms including Terray, Apheris, and TetraScience have simultaneously adopted the platform for foundation model development. The coordinated enterprise adoption signals a shift from experimental AI trials to production-scale deployment in pharmaceutical R&D.

LM Salvado•
Robotics Firms Land Major Industrial Partnerships as Warehouse Systems Hit 98% Handling Rates

Robotics Firms Land Major Industrial Partnerships as Warehouse Systems Hit 98% Handling Rates

Autonomous robotics startups are securing commercial deployments across logistics, manufacturing, and healthcare sectors. Warehouse automation systems now handle 98% of inventory items, while Chinese robotics firms expand into Saudi Arabia's Vision 2030 infrastructure projects. Nuro targets late 2026 for robotaxi production following multi-year autonomous testing.

ViaNews Editorial Team (Finance)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI's 'Show-Me' Reckoning: Earnings Divergence, Executive Exodus, and Regulatory Tightening
Investors are shifting from rewarding AI narratives to demanding tangible results, evidenced by Adobe's weak guidance despite user-growth emphasis, Palantir's stock decline even after winning the Army's TITAN contract, and UiPath's contrasting guidance raise. Simultaneously, high-profile safety-driven departures from Anthropic and Google, plus new regulatory actions (California's under-16 social media ban, Anthropic's misuse-blocking disclosures), signal mounting scrutiny of AI's societal and financial risk profile even as fintech-adjacent funding (Socure) continues.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,288 source documents archived
Query this data → isubstrate.com